| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer
1 company
Orth Andrew C. is a Chief Commercial Officer at KRYS. Recent filings cover 0 purchases and 3 sales. Those positions are worth an estimated $801K at current prices.
Orth Andrew C.'s largest disclosed position is in KRYS as Chief Commercial Officer, worth about $801K. The recent filings there lean toward selling, a net 12,500 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 9, 2023 | KRYS Krystal Biotech, Inc. | Chief Commercial Officer | Sale+OE | 12,500 | $128.61 | $1,607,634.90 | -99.2% | -6.0% | +27.5% |